AI
Friday, December 15, 2023 9:44:44 AM
October Comments:
• The total LLT market was up 1.38% from September while VAZKEPA® was up 10.28%.
• VAZKEPA® increased doses from 116,512 in September to 128,490 in October.
• VAZKEPA® also continued to capture 22.84% from Omacor vs. 21.25% in September.
• VAZKEPA® is very under-utilized in the Non-Statin market (1.3684%), but we’re slowing getting the word out.
https://drive.google.com/file/d/1-Sz4-y9FqQ_k40JjZIMPSGPXmE0czPoT/view?usp=sharing
Recent AMRN News
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • BURU • Oct 15, 2024 8:21 AM
